Question 1

What is Myriad Genetics?

Accepted Answer

Myriad Genetics is a Company.

Question 2

How often does Myriad Genetics appear in global news?

Accepted Answer

Tracked across 5 news events drawn from 33 articles.

Question 3

When was Myriad Genetics first tracked by Ergen?

Accepted Answer

First tracked on May 26, 2026.

Question 4

When was Myriad Genetics last mentioned in news?

Accepted Answer

Last active on Aug 06, 2026.

Question 5

What is Myriad Genetics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 21 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Myriad Genetics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 5 events.

Question 7

What is the most recent event involving Myriad Genetics?

Accepted Answer

Myriad Genetics launches Prolaris + AI Test (May 26, 2026, 6 articles).

Question 8

How did the "Myriad Genetics launches Prolaris + AI Test" event impact Myriad Genetics?

Accepted Answer

Myriad Genetics launched the Prolaris + AI Test, a new prostate cancer biomarker test, which is expected to enhance its product offerings and market position in precision medicine.

Question 9

How did the "Myriad Genetics appoints Raj Jampa CTO" event impact Myriad Genetics?

Accepted Answer

Myriad Genetics appointed Raj Jampa as its new Chief Technology Officer, aiming to strengthen its digital technology foundation, enhance customer experience, and support future growth and value creation. This appointment is expected to modernize its technology infrastructure and scale AI-enabled capabilities.

Question 10

How did the "Myriad Prolaris Test Data Published" event impact Myriad Genetics?

Accepted Answer

Myriad Genetics announced new data from a meta-analysis demonstrating the significant prognostic value of its Prolaris Biopsy Test for localized prostate cancer, which is expected to enhance the test's adoption and market position.

Question 11

How did the "Myriad Genetics launches FirstGene prenatal screen" event impact Myriad Genetics?

Accepted Answer

Myriad Genetics launched the FirstGene screen, enhancing its prenatal screening portfolio and potentially boosting market share.

Question 12

How did the "Myriad Genetics Securities Investigation" event impact Myriad Genetics?

Accepted Answer

Myriad Genetics is the subject of the investigation; its stock fell after reporting weak Q2 results and cutting guidance, and it faces potential securities litigation.

Question 13

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.